All‐cause mortality WMD of · Adults (aged 40 or over) with COPD presenting with 1 or more exacerbations in the previous year. The 2 larger studies (Albert 2011; Sethi…
Antibiotics showed no clear difference in all‐cause mortality WMD of compared with placebo (moderate certainty).
1 finding from 1 review
Mortality before hospital discharge · symptomatic neonates born through meconium‐stained amniotic fluid
Antibiotics showed no clear difference in mortality (before discharge) compared with control (no antibiotics) (low certainty).
1 finding from 1 review
Mortality before hospital discharge · asymptomatic neonates born through meconium‐stained amniotic fluid
Antibiotics showed no clear difference in mortality (before discharge) compared with control (no antibiotics) (low certainty).
1 finding from 1 review
All‐cause mortality · adults with uncomplicated appendicitis
It is very uncertain whether antibiotics changes mortality compared with surgery (very low certainty).
1 finding from 1 review
All‐cause mortality · exacerbations of COPD
Antibiotics showed no clear difference in all‐cause mortality compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortality · adult kidney transplant recipients
Antibiotics showed no clear difference in all‐cause mortality compared with no treatment (low certainty).
1 finding from 1 review
Mortality ‐ not reported · acute asthma exacerbation
The review found no eligible studies for this question.
1 finding from 1 review
All‐cause mortality maximum · patients with coronary heart disease
Antibiotics showed no clear difference in all‐cause mortality at maximum compared with placebo or no intervention (high certainty).
1 finding from 1 review
Maternal and neonatal mortality · women with management of intra‐amniotic infection
1 finding from 1 review
Inpatient mortality · exacerbations of COPD
Antibiotics showed no clear difference in all‐cause mortality ‐ inpatients compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause mortality at 24±6 months · patients with coronary heart disease
Antibiotics leads to higher all‐cause mortality at 24±6 months compared with placebo or no intervention (high certainty).
1 finding from 1 review
ICU mortality · exacerbations of COPD
Antibiotics probably leads to lower all‐cause mortality ‐ ICU patients compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · patients with coronary heart disease
Antibiotics leads to higher cardiovascular mortality at 24±6 months compared with placebo or no intervention (high certainty).
2 findings from 1 review
All‐cause mortality · people undergoing laparotomy for penetrating abdominal trauma
1 finding from 1 review
All‐cause mortality · people undergoing laparotomy for penetrating abdominal trauma
It is very uncertain whether more than 24 hours of antibiotics changes mortality compared with 24 hours of antibiotics (very low certainty).
1 finding from 1 review
Maternal and neonatal mortality · women with management of intra‐amniotic infection
1 finding from 1 review
Neonatal mortality · newborn infants undergoing removal of central venous catheter
1 finding from 1 review
All‐cause mortality ‐ not reported · farmworkers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality (penicillin versus doxycycline) · people with leptospirosis
It is very uncertain whether summary of findings table ‐ Antibiotics changes all‐cause mortality (penicillin versus doxycycline) compared with other antibiotics (very low certainty).
1 finding from 1 review
All‐cause mortality (a cephalosporin (cefotaxime) versus doxycycline) · people with leptospirosis
It is very uncertain whether summary of findings table ‐ Antibiotics changes all‐cause mortality (a cephalosporin (cefotaxime) versus doxycycline) compared with other antibiotics (very low certainty).
1 finding from 1 review